A phase III, multicentre, randomised, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PSD502 in subjects with Premature Ejaculation (PE)

http://isrctn.org/> ◽

10.1186/isrctn71916001 ◽

2012 ◽

Author(s):

Wallace Dinsmore

Keyword(s):

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study

Yearbook of Urology ◽

10.1016/s0084-4071(10)79405-7 ◽

2010 ◽

Vol 2010 ◽

pp. 154-155

Author(s):

A. Shindel

Keyword(s):

Sexual Satisfaction ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency

Download Full-text

1493 PSD 502: A SECOND PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PREMATURE EJACULATION (PE) PATIENTS IN THE US AND EUROPE

The Journal of Urology ◽

10.1016/j.juro.2010.02.1230 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Culley Carson ◽

Ira Sharlip ◽

Mike Wyllie

Keyword(s):

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Second Phase ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5356957.5308055 ◽

2010 ◽

Author(s):

Nelson Bennett

Keyword(s):

Sexual Satisfaction ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency

Download Full-text

Tu1627 - Linaclotide is Effective and Safe for Patients with Chronic Constipation in Japan: A Phase III Randomized, Double-Blind, Placebo-Controlled Study with a Long-Term Open-Label Extension Study

Gastroenterology ◽

10.1016/s0016-5085(18)33271-2 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-973-S-974

Author(s):

Shin Fukudo ◽

Hiroto Miwa ◽

Atsushi Nakajima ◽

Yoshikazu Kinoshita ◽

Masanori Kosako ◽

...

Keyword(s):

Chronic Constipation ◽

Phase Iii ◽

Extension Study ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

PSD502, A NOVEL METERED-DOSE AEROSOL FORMULATION OF LIDOCAINE AND PRILOCAINE, IS A SAFE AND EFFECTIVE TREATMENT FOR PREMATURE EJACULATION (PE); RESULTS OF A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

The Journal of Urology ◽

10.1016/s0022-5347(09)61384-7 ◽

2009 ◽

Vol 181 (4S) ◽

pp. 489-489

Author(s):

Michael G Wyllie ◽

Patricia Heath ◽

W. Wallace Dinsmore

Keyword(s):

Effective Treatment ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2010.01913.x ◽

2010 ◽

Vol 7 (9) ◽

pp. 3179-3189 ◽

Author(s):

Culley Carson ◽

Michael Wyllie

Keyword(s):

Sexual Satisfaction ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency

Download Full-text

High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan

Neurogastroenterology & Motility ◽

10.1111/nmo.13487 ◽

2018 ◽

Vol 31 (1) ◽

pp. e13487 ◽

Author(s):

Shin Fukudo ◽

Hiroto Miwa ◽

Atsushi Nakajima ◽

Yoshikazu Kinoshita ◽

Masanori Kosako ◽

...

Keyword(s):

Chronic Constipation ◽

Phase Iii ◽

Extension Study ◽

Controlled Study ◽

High Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study

Yearbook of Urology ◽

10.1016/j.yuro.2010.12.021 ◽

2011 ◽

Vol 2011 ◽

pp. 158-159

Author(s):

A. Shindel

Keyword(s):

Sexual Satisfaction ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency

Download Full-text

PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study

BJU International ◽

10.1111/j.1464-410x.2009.08456.x ◽

2009 ◽

Vol 103 (7) ◽

pp. 940-949 ◽

Author(s):

W. Wallace Dinsmore ◽

Michael G. Wyllie

Keyword(s):

Sexual Satisfaction ◽

Premature Ejaculation ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency

Download Full-text

Faculty Opinions recommendation of Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090830.544164 ◽

2007 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Controlled Study ◽

Small Cell Lung ◽

Extensive Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Response To Chemotherapy

Download Full-text